Clorox (CLX) Misses Q2 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance

Clorox (NYSE: CLX) reported Q2 EPS of $1.39, $0.05 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

Clorox sees FY2026 EPS of $5.95-$6.30, versus the consensus of $5.95.

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral